News Releases
サブ-ナビゲーション
  • TMS Co., Ltd.
  • Pipeline
  • Investor Relations
    • 現在位置:News Releases
    • Events
    • IR Library
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Frequently Asked Questions
    • Management Policy
    • Disclosure Policy
    • Disclaimer
    • Contact
  • News
  • About Us
  • Business
  • Contact
  • Privacy Policy

News Releases

  • May 02, 2025 Notice of the 21th Annual General Meeting of Shareholders pdf （185KB）
  • Apr 25, 2025 TMS submits CTN for Phase II/III ORION Study Japan Cohort of JX10 to PMDA pdf （158KB）
  • Apr 11, 2025 Presentation Material for the Fiscal Year Ended February 28,2025 pdf （4,531KB）
  • Apr 11, 2025 Non-consolidated Financial Results for the Fiscal Year Ended February 28, 2025 [Japanese GAAP] pdf （358KB）
  • Apr 07, 2025 Notice of TMS-008 Phase I First Data Readout pdf （197KB）
  • Mar 31, 2025 Notice Regarding the Exercise Price Payment of the 10th Share Acquisition Rights (with Moving Strike Warrant) by Third-Party Allotment pdf （148KB）
  • Mar 26, 2025 [Delayed]Notice Regarding the Issuance of the 10th Series of Stock Acquisition Rights (with Moving Strike Warrant) by Third-Party Allotment pdf （366KB）
  • Feb 28, 2025 Notice of Royalty and Compensation Payment pdf （178KB）
  • Feb 28, 2025 Notice of Change in Fiscal Year End (Financial Year End) pdf （199KB）
  • Feb 26, 2025 TMS Co., Ltd. Entered into a Joint Research Agreement with Tokushima University pdf （160KB）
  • Feb 21, 2025 [Delayed]Notice on the Status of JX10 (TMS-007) Clinical Trial Application in China pdf （224KB）
  • Jan 22, 2025 Announcement of presentation on TMS-007(JX10) at International Stroke Conference (ISC) 2025 pdf （197KB）
  • Jan 14, 2025 Non-consolidated Financial Results for the Nine Months Ended November 30, 2024 [Japanese GAAP] pdf （274KB）
  • Jan 06, 2025 TMS to Host an Executive Roundtable at WuXi Global Forum 2025 in San Francisco pdf （182KB）
  • Jan 06, 2025 TMS Issues Letter to Shareholders Highlighting 2024 Accomplishments and Anticipated Milestones for 2025 pdf （248KB）
  • Dec 18, 2024 TMS to participate in Precision AQ Corporate Access Event During J.P.Morgan 2025 Week in San Francisco pdf （201KB）
  • Nov 15, 2024 TMS Co., Ltd. CEO Takuro Wakabayashi Interviewed on US Internet News Media 'Biotech TV’ pdf （179KB）
  • Nov 12, 2024 Notice Concerning the Patent for which TMS is granted license (US) to use pdf （165KB）
  • Nov 08, 2024 Publication of the Phase 2a Clinical Trial Results of JX10 (TMS-007) in the American Heart Association and American Stroke Association’s Stroke pdf （287KB）
  • Oct 16, 2024 [Delayed]Presentation Material for the Six Months Ended August 31,2024 pdf （1,954KB）
  • Oct 15, 2024 Non-consolidated Financial Results for the Six Months Ended August 31, 2024 [Japanese GAAP] pdf （309KB）
  • Jul 17, 2024 TMS Co., Ltd. to participate in BIO Asia-Taiwan 2024 Investment Summit pdf （98KB）
  • Jul 12, 2024 Non-consolidated Financial Results for the Three Months Ended May 31, 2024 [Japanese GAAP] pdf （273KB）
  • Jul 03, 2024 TMS Enters into Exclusive License Agreement with Hokkaido University to In-License Novel Therapeutic Candidate for Spinal Cord Injury pdf （223KB）
  • Jun 19, 2024 Notice of Dosing to the First Subject in TMS-008 Phase I Clinical Trial pdf （172KB）
  • May 02, 2024 Notice of the 20th Annual General Meeting of Shareholders pdf （97KB）
  • Apr 17, 2024 Presentation Material for the Fiscal Year Ended February 29, 2024 pdf （2,178KB）
  • Apr 12, 2024 Non-consolidated Financial Results for the Fiscal Year Ended February 29, 2024 [Japanese GAAP] pdf （269KB）
  • Feb 29, 2024 TMS submits Clinical Trial Plan Notification for TMS-008 Phase I clinical trial in Japan pdf （203KB）
  • Feb 20, 2024 JIXING Announced the First Subject Dosing of JX09 Phase I Clinical Trial pdf （120KB）
  • Jan 16, 2024 [Delayed]Non-consolidated Financial Results for the Nine Months Ended November 30, 2023 [Japanese GAAP] pdf （248KB）
  • Jan 12, 2024 [Delayed]Notice of Strategic Alliance between TMS and JIXING pdf （391KB）
  • Dec 11, 2023 Notice Concerning the Patent for which TMS is granted license (China) to use pdf （144KB）
  • Oct 26, 2023 [Delayed]Presentation Material for the Six Months Ended August 31, 2023 pdf （1,978KB）
  • Oct 19, 2023 TMS Co., Ltd. entered into Joint Research Agreement with Teikyo University pdf （165KB）
  • Oct 19, 2023 TMS Co., Ltd. entered into Joint Research Agreement with Hokkaido University and Kanazawa University pdf （125KB）
  • Oct 13, 2023 Non-consolidated Financial Results for the Six Months Ended August 31, 2023 [Japanese GAAP] pdf （201KB）
  • Oct 06, 2023 [Delayed]Notice Concerning the Patent for which TMS is granted license to use pdf （143KB）
  • Sep 07, 2023 TMS was selected as a finalist of the Citeline Pharma Intelligence Awards Japan 2023 pdf （301KB）
  • Jul 28, 2023 Notice regarding the development of TMS-007 (BIIB131) pdf （115KB）
  • Jul 14, 2023 Non-consolidated Financial Results for the Three Months Ended May 31, 2023 [Japanese GAAP] pdf （226KB）
  • Jul 14, 2023 Non-consolidated Financial Results for the Three Months Ended May 31, 2023 [Japanese GAAP] pdf （226KB）
  • Jul 10, 2023 Notice regarding the Determination of details of Issuance of Share Acquisition Rights as Stock Options pdf （112KB）
  • Jun 29, 2023 TMS Co., Ltd. entered into Joint Research Agreement with the Microbial Chemistry Research Foundation pdf （147KB）
  • Jun 20, 2023 [Delayed]Notice regarding the Issuance of Share Acquisition Rights as Stock Options pdf （259KB）
  • Jun 05, 2023 [Delayed]Annual Securities Report for the Fiscal Year Ended February 28, 2023 pdf （5,361KB）
  • May 31, 2023 TMS Co., Ltd. to participate in the Jefferies Healthcare Conference pdf （141KB）
  • May 09, 2023 TMS Co., Ltd. signed Option Agreement with Hokkaido University pdf （145KB）
  • May 08, 2023 Notice of the 19th Annual General Meeting of Shareholders pdf （128KB）
  • Apr 27, 2023 [Delayed]Notice regarding the determination of remuneration for Granting Stock Acquisition Rights as Stock Option to Board Members pdf （176KB）
  • Apr 26, 2023 Notice regarding the development of TMS-007 pdf （96KB）
  • Apr 14, 2023 Presentation material for the Fiscal Year Ended February 28, 2023 pdf （2,221KB）
  • Apr 14, 2023 Non-consolidated Financial Results for the Fiscal Year Ended February 28, 2023 [Japanese GAAP] pdf （341KB）
  • Mar 15, 2023 Notice regarding the Changes of Management Structure pdf （140KB）
  • Mar 13, 2023 Notice regarding the development of TMS-007(BIIB131) pdf （114KB）
  • Jan 23, 2023 The initiation of analyst coverage by Jefferies
  • Jan 16, 2023 [Delayed]Non-consolidated Financial Results for the Nine Months Ended November 30, 2022[Japanese GAAP] pdf （171KB）
  • Jan 16, 2023 [Delayed]Notice Concerning Revisions to Full-Year Financial Results Forecasts pdf （134KB）
  • About Us
  • Letter from CEO
  • Our Mission
  • Company Info
  • Management Team
  • Board of Directors
  • History

About Us

  • Business
  • Pipeline
  • Science
  • Business Model

Business

Pipeline

  • Investor Relations
  • News Releases
  • Events
  • IR Library
  • Financial Information
  • Stock Information
  • Corporate Governance
  • Frequently Asked Questions
  • Management Policy
  • Disclosure Policy
  • Disclaimer
  • Contact

Investor Relations

News

  • JP
  • EN
  • navi-3way
  • JP
  • EN

ページの先頭へ
ページの先頭へ
  • CLOSE
  • MENU

サイト内検索

Cookie Policy

We use cookies to provide you with a better browsing experience.
Please confirm that you agree to our use of cookies by clicking Yes.
If you continue to browse this website even without agreeing to our use of cookies,
we consider that you have consented to our use of cookies.

Yes

About Us

  • Letter from CEO
  • Our Mission
  • Company Info
  • Management Team
  • Board of Directors
  • History

Business

  • Pipeline
  • Science
  • Business Model

Pipeline

  • Pipeline
  • TMS-007
  • TMS-008
  • TMS-010

IR

  • News Releases
  • Events
  • IR Library
  • Financial Information
  • Stock Information
  • Corporate Governance
  • Frequently Asked Questions
  • Management Policy
  • Disclosure Policy
  • Disclaimer
  • Contact

News

  • Contact
  • Privacy Policy

© 2021 TMS Co., Ltd.